View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 25, 2011

Covidien reports six-month plaque excision study results

Covidien has reported six-month results from a study assessing the effectiveness of plaque excision as a frontline therapy for the treatment of peripheral arterial disease.

Covidien has reported six-month results from a study assessing the effectiveness of plaque excision as a frontline therapy for the treatment of peripheral arterial disease.

The study is evaluating the one-year patency rates in patients with claudication and limb salvage in patients with critical limb ischaemia after treatment with Covidien’s catheter-based SilverHawk/TurboHawk plaque excision systems.

Of the 800 patients enrolled, 624 patients had a six-month follow-up. Of these, primary patency in claudicants was 94.1% and freedom from major unplanned amputation of the target limb at six months in critical limb ischaemia patients was 97.3%.

The final results at 12 months will be available in 2012.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management